In this episode, we will review evidence associated with once weekly pipeline agent insulin icodec.

Each month, APhA will release two podcast episodes offering a fresh dose of education highlights, practice pearls, and insights to inform your pharmacy practice and advance patient care. Listen to new episodes at your convenience! Both members and nonmembers can log into their APhA pharmacist.com Learning Library account to successfully complete a short assessment at the end of each month to earn 0.5 hours of CE credits (.05 CEU).

Tune in now on our website or subscribe via YouTube, Spotify, or Apple Podcasts.

Disclaimer: The content is intended for informational purposes only and should not be considered or taken as medical advice. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or positions of any entities they represent or its employees.

In this episode, we will review evidence associated with once weekly pipeline agent insulin efsitora alfa.

Each month, APhA will release two podcast episodes offering a fresh dose of education highlights, practice pearls, and insights to inform your pharmacy practice and advance patient care. Listen to new episodes at your convenience! Both members and nonmembers can log into their APhA pharmacist.com Learning Library account to successfully complete a short assessment at the end of each month to earn 0.5 hours of CE credits (.05 CEU).

Tune in now on our website or subscribe via YouTube, Spotify, or Apple Podcasts.

Disclaimer: The content is intended for informational purposes only and should not be considered or taken as medical advice. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or positions of any entities they represent or its employees.

In this episode of the First Fill, Dr. Allison Reed, PharmD, BCPS, BCOP a clinical pharmacy specialist in oncology discusses her perspective on how the recent pooled cohort published in the Lancet impacts what we know on the risk versus benefit of hormone replacement therapy in young women.

Each month, APhA will release two podcast episodes offering a fresh dose of education highlights, practice pearls, and insights to inform your pharmacy practice and advance patient care. Listen to new episodes at your convenience! Both members and nonmembers can log into their APhA pharmacist.com Learning Library account to successfully complete a short assessment at the end of each month to earn 0.5 hours of CE credits (.05 CEU).

Tune in now on our website or subscribe via YouTube, Spotify, or Apple Podcasts.

Disclaimer: The content is intended for informational purposes only and should not be considered or taken as medical advice. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or positions of any entities they represent or its employees.

In this episode of The First Fill, we will review a recent study published in the Lancet examining hormone therapy use and young-onset breast cancer.

Each month, APhA will release two podcast episodes offering a fresh dose of education highlights, practice pearls, and insights to inform your pharmacy practice and advance patient care. Listen to new episodes at your convenience! Both members and nonmembers can log into their APhA pharmacist.com Learning Library account to successfully complete a short assessment at the end of each month to earn 0.5 hours of CE credits (.05 CEU).

Tune in now on our website or subscribe via YouTube, Spotify, or Apple Podcasts.

Disclaimer: The content is intended for informational purposes only and should not be considered or taken as medical advice. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or positions of any entities they represent or its employees.

In this episode of the First Fill, Dr. Ryan Waldschmidt, PharmD, assistant professor of pharmacy practice at the university of Findlay discusses his experience with implementing the updated American college of Cardiology/American Heart Association Clinical Practice guidelines for the prevention, detection, evaluation and management of high blood pressure in adults.

Each month, APhA will release two podcast episodes offering a fresh dose of education highlights, practice pearls, and insights to inform your pharmacy practice and advance patient care. Listen to new episodes at your convenience! Both members and nonmembers can log into their APhA pharmacist.com Learning Library account to successfully complete a short assessment at the end of each month to earn 0.5 hours of CE credits (.05 CEU).

Tune in now on our website or subscribe via YouTube, Spotify, or Apple Podcasts.

Disclaimer: The content is intended for informational purposes only and should not be considered or taken as medical advice. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or positions of any entities they represent or its employees.

In this episode of The First Fill, we will review the American college of cardiology/American Health Association recently published guidelines for the prevention, detection, evaluation and management of high blood pressure in adults. Key updates compared to the 2017 guidelines for pharmacists to be aware of will be discussed.

Each month, APhA will release two podcast episodes offering a fresh dose of education highlights, practice pearls, and insights to inform your pharmacy practice and advance patient care. Listen to new episodes at your convenience! Both members and nonmembers can log into their APhA pharmacist.com Learning Library account to successfully complete a short assessment at the end of each month to earn 0.5 hours of CE credits (.05 CEU).

Tune in now on our website or subscribe via YouTube, Spotify, or Apple Podcasts.

Disclaimer: The content is intended for informational purposes only and should not be considered or taken as medical advice. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or positions of any entities they represent or its employees.

In this episode, clinical research scientist Jennifer Cocohoba discusses solutions to barriers of effective HIV care, lenacapavir’s place in in the HIV prevention landscape and things that pharmacists can do to ensure that patients have access to the medications they need.

Each month, APhA will release two podcast episodes offering a fresh dose of education highlights, practice pearls, and insights to inform your pharmacy practice and advance patient care. Listen to new episodes at your convenience! Both members and nonmembers can log into their APhA pharmacist.com Learning Library account to successfully complete a short assessment at the end of each month to earn 0.5 hours of CE credits (.05 CEU).

Tune in now on our website or subscribe via YouTube, Spotify, or Apple Podcasts.

Disclaimer: The content is intended for informational purposes only and should not be considered or taken as medical advice. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or positions of any entities they represent or its employees.

In this episode of The First Fill, we will review two recent new drug approvals, gepotidacin for UTI and lenacapavir for treatment and prevention of HIV. You'll hear about outcomes from clinical trials and patient counseling points for the new agents.

Each month, APhA will release two podcast episodes offering a fresh dose of education highlights, practice pearls, and insights to inform your pharmacy practice and advance patient care. Listen to new episodes at your convenience! Both members and nonmembers can log into their APhA pharmacist.com Learning Library account to successfully complete a short assessment at the end of each month to earn 0.5 hours of CE credits (.05 CEU).

Tune in now on our website or subscribe via YouTube, Spotify, or Apple Podcasts.

Disclaimer: The content is intended for informational purposes only and should not be considered or taken as medical advice. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the opinions or positions of any entities they represent or its employees.